Michael Byrnes - Jun 20, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Chief Financial Officer
Signature
/s/ Michael Byrnes
Stock symbol
EFTR
Transactions as of
Jun 20, 2022
Transactions value $
$0
Form type
4
Date filed
6/22/2022, 04:17 PM
Previous filing
Jun 7, 2022
Next filing
Nov 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +236K $0.00 236K Jun 20, 2022 Common Stock 236K $1.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 50% on June 20, 2023, and in 12 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.